Metraipolis › archive › dc_53facbf9ad68

HCAR score as a prognostic biomarker of survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy — Europe PMC PMID:41347597

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41347597
DOI: 10.17305/bb.2025.13398
License (as archived): solo-consultazione
Archived: 2026-11-07T21:57:02.071Z
SHA-256 of the archived text: 81180c299ac4f17f9e71d30c32c46f8cc6d4f6e5c8620d7a6b2864161128c216
Stable URL of this page: https://metraipolis.com/documento/dc_53facbf9ad68

How to cite

HCAR score as a prognostic biomarker of survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy — Europe PMC PMID:41347597 — Europe PMC (en), https://europepmc.org/article/MED/41347597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53facbf9ad68 (Metraipolis archive dc_53facbf9ad68, sha256 81180c299ac4f17f9e71d30c32c46f8cc6d4f6e5c8620d7a6b2864161128c216)

BibTeX

@misc{dc53facbf9ad68,
  title = {HCAR score as a prognostic biomarker of survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy — Europe PMC PMID:41347597},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41347597},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53facbf9ad68; sha256 81180c299ac4f17f9e71d30c32c46f8cc6d4f6e5c8620d7a6b2864161128c216},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41347597. Agents can read the archived copy with the MCP tool read_document.